SyntheticGestalt collaborates with Enamine to create AI-based model to facilitate drug discovery
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Launch innovative vitamin sublingual sprays
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
The company has received five final approvals
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
Subscribe To Our Newsletter & Stay Updated